A citation-based method for searching scientific literature

Zhi-Hua Yang, Chang-He Shi, Li-Na Zhou, Yu-Sheng Li, Jing Yang, Yu-Tao Liu, Cheng-Yuan Mao, Hai-Yang Luo, Guo-Wang Xu, Yu-Ming Xu. Front Mol Neurosci 2019
Times Cited: 12







List of co-cited articles
47 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Scale for the assessment and rating of ataxia: development of a new clinical scale.
T Schmitz-Hübsch, S Tezenas du Montcel, L Baliko, J Berciano, S Boesch, C Depondt, P Giunti, C Globas, J Infante, J-S Kang,[...]. Neurology 2006
941
25

Cytokines in Machado Joseph Disease/Spinocerebellar Ataxia 3.
Gerson da Silva Carvalho, Jonas Alex Morales Saute, Clarissa Branco Haas, Vitor Rocco Torrez, Andressa Wigner Brochier, Gabriele Nunes Souza, Gabriel Vasata Furtado, Tailise Gheno, Aline Russo, Thais Lampert Monte,[...]. Cerebellum 2016
18
25

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Adriano M de Assis, Jonas Alex Morales Saute, Aline Longoni, Clarissa Branco Haas, Vitor Rocco Torrez, Andressa Wigner Brochier, Gabriele Nunes Souza, Gabriel Vasata Furtado, Tailise Conte Gheno, Aline Russo,[...]. Front Neurol 2017
31
25

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.
Y Kawaguchi, T Okamoto, M Taniwaki, M Aizawa, M Inoue, S Katayama, H Kawakami, S Nakamura, M Nishimura, I Akiguchi. Nat Genet 1994
25

Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7.
Udo Rüb, Ludger Schöls, Henry Paulson, Georg Auburger, Pawel Kermer, Joanna C Jen, Kay Seidel, Horst-Werner Korf, Thomas Deller. Prog Neurobiol 2013
177
25

Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
T Schmitz-Hübsch, M Coudert, P Bauer, P Giunti, C Globas, L Baliko, A Filla, C Mariotti, M Rakowicz, P Charles,[...]. Neurology 2008
168
16

Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion.
G David, N Abbas, G Stevanin, A Dürr, G Yvert, G Cancel, C Weber, G Imbert, F Saudou, E Antoniou,[...]. Nat Genet 1997
603
16

In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7.
Isaac M Adanyeguh, Pierre-Gilles Henry, Tra M Nguyen, Daisy Rinaldi, Celine Jauffret, Romain Valabregue, Uzay E Emir, Dinesh K Deelchand, Alexis Brice, Lynn E Eberly,[...]. Mov Disord 2015
41
16

Oxidative Stress in Spinocerebellar Ataxia Type 7 Is Associated with Disease Severity.
Y Torres-Ramos, A Montoya-Estrada, B Cisneros, K Tercero-Pérez, G León-Reyes, N Leyva-García, Oscar Hernández-Hernández, Jonathan J Magaña. Cerebellum 2018
12
16

Subcutaneous insulin-like growth factor-1 treatment in spinocerebellar ataxias: an open label clinical trial.
Javier Arpa, Irene Sanz-Gallego, Josmarlin Medina-Báez, Luis Valmor Cruz Portela, Laura Bannach Jardim, Ignacio Torres-Aleman, Jonas Alex Morales Saute. Mov Disord 2011
24
16

FOXO4-dependent upregulation of superoxide dismutase-2 in response to oxidative stress is impaired in spinocerebellar ataxia type 3.
Julieta Araujo, Peter Breuer, Susanne Dieringer, Sybille Krauss, Stephanie Dorn, Katrin Zimmermann, Alexander Pfeifer, Thomas Klockgether, Ullrich Wuellner, Bernd O Evert. Hum Mol Genet 2011
67
16

Serum insulin-like system alterations in patients with spinocerebellar ataxia type 3.
Jonas Alex Morales Saute, Andrew Chaves Feitosa da Silva, Alexandre Pastoris Muller, Gisele Hansel, Alexandre Silva de Mello, Fábio Maeda, Leonardo Vedolin, Maria Luiza Saraiva-Pereira, Diogo Onofre Souza, Javier Arpa,[...]. Mov Disord 2011
21
16

Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease.
Philipp Koch, Peter Breuer, Michael Peitz, Johannes Jungverdorben, Jaideep Kesavan, Daniel Poppe, Jonas Doerr, Julia Ladewig, Jerome Mertens, Thomas Tüting,[...]. Nature 2011
226
16

Nerve growth factor for the treatment of spinocerebellar ataxia type 3: an open-label study.
Song Tan, Rui-Hao Wang, Hui-Xia Niu, Chang-He Shi, Cheng-Yuan Mao, Rui Zhang, Bo Song, Shi-Lei Sun, Xin-Jing Liu, Hai-Man Hou,[...]. Chin Med J (Engl) 2015
10
20

SUMOylation of the brain-predominant Ataxin-3 isoform modulates its interaction with p97.
Bruno Almeida, Isabel A Abreu, Carlos A Matos, Joana S Fraga, Sara Fernandes, Maria G Macedo, Ricardo Gutiérrez-Gallego, Pedro José Barbosa Pereira, Ana Luísa Carvalho, Sandra Macedo-Ribeiro. Biochim Biophys Acta 2015
26
16

CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3.
Thorsten Mueller, Peter Breuer, Ina Schmitt, Jochen Walter, Bernd O Evert, Ullrich Wüllner. Hum Mol Genet 2009
68
16

Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias.
Ronald A M Buijsen, Lodewijk J A Toonen, Sarah L Gardiner, Willeke M C van Roon-Mom. Neurotherapeutics 2019
40
16

Targeting Ubiquitin Proteasome Pathway with Traditional Chinese Medicine for Treatment of Spinocerebellar Ataxia Type 3.
I-Cheng Chen, Chia-Ning Chang, Wan-Ling Chen, Te-Hsien Lin, Chih-Ying Chao, Chih-Hsin Lin, Hsuan-Yuan Lin, Mei-Ling Cheng, Mu-Chun Chiang, Jung-Yaw Lin,[...]. Am J Chin Med 2019
8
25

T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse.
An-Hsun Chou, Ying-Ling Chen, Ching-Chi Chiu, Shin-Je Yuan, Yi-Hsin Weng, Tu-Hsueh Yeh, Yun-Lian Lin, Jim-Min Fang, Hung-Li Wang. Neuropharmacology 2015
18
16

GST-4-Dependent Suppression of Neurodegeneration in C. elegans Models of Parkinson's and Machado-Joseph Disease by Rapeseed Pomace Extract Supplementation.
Franziska Pohl, Andreia Teixeira-Castro, Marta Daniela Costa, Victoria Lindsay, Juliana Fiúza-Fernandes, Marie Goua, Giovanna Bermano, Wendy Russell, Patrícia Maciel, Paul Kong Thoo Lin. Front Neurosci 2019
13
16

Novel candidate blood-based transcriptional biomarkers of Machado-Joseph disease.
Mafalda Raposo, Conceição Bettencourt, Patrícia Maciel, Fuying Gao, Amanda Ramos, Nadiya Kazachkova, João Vasconcelos, Teresa Kay, Ana João Rodrigues, Bruno Bettencourt,[...]. Mov Disord 2015
19
16

n-Butylidenephthalide exhibits protection against neurotoxicity through regulation of tryptophan 2, 3 dioxygenase in spinocerebellar ataxia type 3.
Karthyayani Rajamani, Jen-Wei Liu, Cheng-Han Wu, I-Tsang Chiang, Deng-Huwei You, Si-Yin Lin, Dean-Kuo Hsieh, Shinn-Zong Lin, Horng-Jyh Harn, Tzyy-Wen Chiou. Neuropharmacology 2017
16
16

Cordycepin activates autophagy through AMPK phosphorylation to reduce abnormalities in Machado-Joseph disease models.
Adriana Marcelo, Filipa Brito, Sara Carmo-Silva, Carlos A Matos, João Alves-Cruzeiro, Ana Vasconcelos-Ferreira, Rebekah Koppenol, Liliana Mendonça, Luís Pereira de Almeida, Clévio Nóbrega. Hum Mol Genet 2019
28
16

Calpain-1 ablation partially rescues disease-associated hallmarks in models of Machado-Joseph disease.
Jonasz J Weber, Eva Haas, Yacine Maringer, Stefan Hauser, Nicolas L P Casadei, Athar H Chishti, Olaf Riess, Jeannette Hübener-Schmid. Hum Mol Genet 2020
9
22

Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy.
Carlos A Matos, Luís Pereira de Almeida, Clévio Nóbrega. J Neurochem 2019
42
16

Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence.
Ulrike Bichelmeier, Thorsten Schmidt, Jeannette Hübener, Jana Boy, Lukas Rüttiger, Karina Häbig, Sven Poths, Michael Bonin, Marlies Knipper, Werner J Schmidt,[...]. J Neurosci 2007
134
16

Karyopherin α-3 is a key protein in the pathogenesis of spinocerebellar ataxia type 3 controlling the nuclear localization of ataxin-3.
Anna Sergeevna Sowa, Elodie Martin, Inês Morgado Martins, Jana Schmidt, Reinhard Depping, Jonasz Jeremiasz Weber, Franziska Rother, Enno Hartmann, Michael Bader, Olaf Riess,[...]. Proc Natl Acad Sci U S A 2018
27
16

Integrative omics for health and disease.
Konrad J Karczewski, Michael P Snyder. Nat Rev Genet 2018
281
16

LC-MS-based metabolomics.
Bin Zhou, Jun Feng Xiao, Leepika Tuli, Habtom W Ressom. Mol Biosyst 2012
236
16


Pathogenesis of SCA3 and implications for other polyglutamine diseases.
Hayley S McLoughlin, Lauren R Moore, Henry L Paulson. Neurobiol Dis 2020
34
16

Brain pathology of spinocerebellar ataxias.
Kay Seidel, Sonny Siswanto, Ewout R P Brunt, Wilfred den Dunnen, Horst-Werner Korf, Udo Rüb. Acta Neuropathol 2012
214
16

Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6.
Christoph Globas, Sophie Tezenas du Montcel, Laslo Baliko, Syliva Boesch, Chantal Depondt, Stefano DiDonato, Alexandra Durr, Alessandro Filla, Thomas Klockgether, Caterina Mariotti,[...]. Mov Disord 2008
75
16

Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Heike Jacobi, Kathrin Reetz, Sophie Tezenas du Montcel, Peter Bauer, Caterina Mariotti, Lorenzo Nanetti, Maria Rakowicz, Anna Sulek, Alexandra Durr, Perrine Charles,[...]. Lancet Neurol 2013
108
16

SCA Functional Index: a useful compound performance measure for spinocerebellar ataxia.
T Schmitz-Hübsch, P Giunti, D A Stephenson, C Globas, L Baliko, F Saccà, C Mariotti, M Rakowicz, S Szymanski, J Infante,[...]. Neurology 2008
81
16

Abnormal eyeblink conditioning is an early marker of cerebellar dysfunction in preclinical SCA3 mutation carriers.
J van Gaalen, R P P W M Maas, E F Ippel, M W Elting, K Y van Spaendonck-Zwarts, S Vermeer, C Verschuuren-Bemelmans, D Timmann, Bart P van de Warrenburg. Exp Brain Res 2019
6
33

Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6.
Sophie Tezenas du Montcel, Alexandra Durr, Maria Rakowicz, Lorenzo Nanetti, Perrine Charles, Anna Sulek, Caterina Mariotti, Rafal Rola, Ludger Schols, Peter Bauer,[...]. J Med Genet 2014
42
16

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology.
P Trouillas, T Takayanagi, M Hallett, R D Currier, S H Subramony, K Wessel, A Bryer, H C Diener, S Massaquoi, C M Gomez,[...]. J Neurol Sci 1997
890
16

Oculomotor deficits in spinocerebellar ataxia type 3: Potential biomarkers of preclinical detection and disease progression.
Chao Wu, Ding-Bang Chen, Li Feng, Xiang-Xue Zhou, Ji-Wei Zhang, Hua-Jing You, Xiu-Ling Liang, Zhong Pei, Xun-Hua Li. CNS Neurosci Ther 2017
22
16

Structural signature of SCA3: From presymptomatic to late disease stages.
Thiago Junqueira Ribeiro Rezende, Jean Levi Ribeiro de Paiva, Alberto Rolim Muro Martinez, Iscia Lopes-Cendes, José Luiz Pedroso, Orlando Graziani Povoas Barsottini, Fernando Cendes, Marcondes C França. Ann Neurol 2018
37
16

Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
Quan-Fu Li, Yi Dong, Lu Yang, Juan-Juan Xie, Yin Ma, Yi-Chu Du, Hao-Ling Cheng, Wang Ni, Zhi-Ying Wu. Mol Neurodegener 2019
31
16

Nystagmus as an early ocular alteration in Machado-Joseph disease (MJD/SCA3).
Mafalda Raposo, João Vasconcelos, Conceição Bettencourt, Teresa Kay, Paula Coutinho, Manuela Lima. BMC Neurol 2014
17
16

Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment.
Sophie Tezenas du Montcel, Perrine Charles, Pascale Ribai, Cyril Goizet, Alice Le Bayon, Pierre Labauge, Lucie Guyant-Maréchal, Sylvie Forlani, Celine Jauffret, Nadia Vandenberghe,[...]. Brain 2008
55
16

Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches.
Luis C Velázquez-Pérez, Roberto Rodríguez-Labrada, Juan Fernandez-Ruiz. Front Neurol 2017
40
16

Spinocerebellar ataxia: an update.
Roisin Sullivan, Wai Yan Yau, Emer O'Connor, Henry Houlden. J Neurol 2019
59
16

Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.
V Campuzano, L Montermini, M D Moltò, L Pianese, M Cossée, F Cavalcanti, E Monros, F Rodius, F Duclos, A Monticelli,[...]. Science 1996
16

Hereditary ataxias and paraparesias: clinical and genetic update.
Livia Parodi, Giulia Coarelli, Giovanni Stevanin, Alexis Brice, Alexandra Durr. Curr Opin Neurol 2018
46
16

Plasma and urine metabolic profiles are reflective of altered beta-oxidation in non-diabetic obese subjects and patients with type 2 diabetes mellitus.
Jesús Zacarías Villarreal-Pérez, Jesús Zacarías Villarreal-Martínez, Fernando Javier Lavalle-González, María Del Rosario Torres-Sepúlveda, Consuelo Ruiz-Herrera, Ricardo Martín Cerda-Flores, Erik Rubén Castillo-García, Irám Pablo Rodríguez-Sánchez, Laura Elia Martínez de Villarreal. Diabetol Metab Syndr 2014
30
8

Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease.
Daniel Stoessel, Claudia Schulte, Marcia C Teixeira Dos Santos, Dieter Scheller, Irene Rebollo-Mesa, Christian Deuschle, Dirk Walther, Nicolas Schauer, Daniela Berg, Andre Nogueira da Costa,[...]. Front Aging Neurosci 2018
36
8

Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7).
G David, A Dürr, G Stevanin, G Cancel, N Abbas, A Benomar, S Belal, A S Lebre, M Abada-Bendib, D Grid,[...]. Hum Mol Genet 1998
206
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.